These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6253859)

  • 1. Suppression of the leukocyte adherence inhibition response to murine-sarcoma-virus-induced tumors by tumor-associated suppressor cells.
    Mortensen RF; Elson LM
    Oncology; 1980; 37(6):406-10. PubMed ID: 6253859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. II. Requirement for T-cell subpopulations and macrophages.
    Sarlo KT; Mortensen RF
    Cell Immunol; 1983 Jul; 79(2):211-9. PubMed ID: 6307531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1221-7. PubMed ID: 228106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the immune response in tumor-bearing mice. I. Response to virus-producing tumor cells and non-virus-producing tumor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1215-20. PubMed ID: 228105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine transmissible venereal sarcoma: leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors at different stages of growth.
    Harding MW; Yang TJ
    Int J Cancer; 1981 Mar; 27(3):349-55. PubMed ID: 7026460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. I. Cell requirements, specificity, lack of H-2 restriction, and role of antibody.
    Mortensen RF; Elson LM
    J Immunol; 1980 May; 124(5):2316-23. PubMed ID: 6154099
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of the immune response in tumor-bearing mice. III. Induction of functionally suppressive antigen-driven macrophages.
    Bluestone JA; Lopez C
    Cancer Invest; 1983; 1(1):5-13. PubMed ID: 6199094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.
    Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1975 Oct; 55(4):971-5. PubMed ID: 171434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N; Boone CW; Holden HT; Herberman RB
    Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production.
    Varesio L; Holden HT
    Cell Immunol; 1980 Nov; 56(1):16-28. PubMed ID: 6253087
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors.
    Gerson J; Varesio L; Herberman RB
    Int J Cancer; 1981 Feb; 27(2):243-8. PubMed ID: 6457000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional heterogeneity and T cell-dependent activation of macrophages from murine sarcoma virus (MSV)-induced tumors.
    Holden HT; Varesio L; Taniyama T; Puccetti P
    Adv Exp Med Biol; 1979; 121B():509-20. PubMed ID: 232622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Defects in cell-mediated and humoral immunity in tumor-bearing mice. Evidence and characterization of suppressor cells ].
    Siegl E; Günther J; Schulze HA; Brock J
    Allerg Immunol (Leipz); 1981; 27(3):153-61. PubMed ID: 6214936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
    Harding MW; Yang TJ
    Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.